{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:16:22Z","timestamp":1790644582313,"version":"4.1.0"},"reference-count":52,"publisher":"American Diabetes Association","issue":"7","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":2999,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,7,1]]},"abstract":"<jats:p>We measured the mRNA and protein expression of the key gluconeogenic enzymes in human liver biopsy specimens and found that only hepatic pyruvate carboxylase protein levels related strongly with glycemia. We assessed the role of pyruvate carboxylase in regulating glucose and lipid metabolism in rats through a loss-of-function approach using a specific antisense oligonucleotide (ASO) to decrease expression predominantly in liver and adipose tissue. Pyruvate carboxylase ASO reduced plasma glucose concentrations and the rate of endogenous glucose production in vivo. Interestingly, pyruvate carboxylase ASO also reduced adiposity, plasma lipid concentrations, and hepatic steatosis in high fat\u2013fed rats and improved hepatic insulin sensitivity. Pyruvate carboxylase ASO had similar effects in Zucker Diabetic Fatty rats. Pyruvate carboxylase ASO did not alter de novo fatty acid synthesis, lipolysis, or hepatocyte fatty acid oxidation. In contrast, the lipid phenotype was attributed to a decrease in hepatic and adipose glycerol synthesis, which is important for fatty acid esterification when dietary fat is in excess. Tissue-specific inhibition of pyruvate carboxylase is a potential therapeutic approach for nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes.<\/jats:p>","DOI":"10.2337\/db12-1311","type":"journal-article","created":{"date-parts":[[2013,2,20]],"date-time":"2013-02-20T02:39:06Z","timestamp":1361327946000},"page":"2183-2194","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":127,"title":["Targeting Pyruvate Carboxylase Reduces Gluconeogenesis and Adiposity and Improves Insulin Resistance"],"prefix":"10.2337","volume":"62","author":[{"given":"Naoki","family":"Kumashiro","sequence":"first","affiliation":[{"name":"Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut"},{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A.","family":"Beddow","sequence":"additional","affiliation":[{"name":"Veterans Affairs Medical Center, West Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Vatner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin K.","family":"Majumdar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Cantley","sequence":"additional","affiliation":[{"name":"Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut"},{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fitsum","family":"Guebre-Egziabher","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Fat","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blas","family":"Guigni","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Jurczak","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas L.","family":"Birkenfeld","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Kahn","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryce K.","family":"Perler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Puchowicz","sequence":"additional","affiliation":[{"name":"Department of Nutrition, Case Western Reserve University, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vara Prasad","family":"Manchem","sequence":"additional","affiliation":[{"name":"ISIS Pharmaceuticals, Carlsbad, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Bhanot","sequence":"additional","affiliation":[{"name":"ISIS Pharmaceuticals, Carlsbad, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Still","sequence":"additional","affiliation":[{"name":"Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn S.","family":"Gerhard","sequence":"additional","affiliation":[{"name":"Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitt Falk","family":"Petersen","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary W.","family":"Cline","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald I.","family":"Shulman","sequence":"additional","affiliation":[{"name":"Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut"},{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"},{"name":"Department of Cellular & Molecular Physiology, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varman T.","family":"Samuel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut"},{"name":"Veterans Affairs Medical Center, West Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2013,6,14]]},"reference":[{"key":"2022031223455349000_B1","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1172\/JCI115997","article-title":"Increased rate of gluconeogenesis in type II diabetes mellitus. A 17C nuclear magnetic resonance study","volume":"90","author":"Magnusson","year":"1992","journal-title":"J Clin Invest"},{"key":"2022031223455349000_B2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7326\/0003-4819-128-3-199802010-00002","article-title":"Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial","volume":"128","author":"Maggs","year":"1998","journal-title":"Ann Intern Med"},{"key":"2022031223455349000_B3","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2337\/diabetes.49.12.2063","article-title":"Mechanism by which metformin reduces glucose production in type 2 diabetes","volume":"49","author":"Hundal","year":"2000","journal-title":"Diabetes"},{"key":"2022031223455349000_B4","doi-asserted-by":"crossref","first-page":"PC17","DOI":"10.1016\/S0021-9258(18)69442-6","article-title":"Formation of oxaloacetate from pyruvate and carbon dioxide","volume":"235","author":"Utter","year":"1960","journal-title":"J Biol Chem"},{"key":"2022031223455349000_B5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1126\/science.120.3125.851","article-title":"Glucose-6-phosphatase studies in fasting","volume":"120","author":"Weber","year":"1954","journal-title":"Science"},{"key":"2022031223455349000_B6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0021-9258(18)65698-4","article-title":"Purification of oxalacetic carboxylase from chicken liver","volume":"207","author":"Utter","year":"1954","journal-title":"J Biol Chem"},{"key":"2022031223455349000_B7","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0021-9258(18)65205-6","article-title":"Purification and properties of fructose-1, 6-diphosphatase","volume":"221","author":"McGilvery","year":"1956","journal-title":"J Biol Chem"},{"key":"2022031223455349000_B8","doi-asserted-by":"crossref","first-page":"27606","DOI":"10.1074\/jbc.M201429200","article-title":"Conserved amino acids within CCAAT enhancer-binding proteins (C\/EBP(alpha) and beta) regulate phosphoenolpyruvate carboxykinase (PEPCK) gene expression","volume":"277","author":"Jurado","year":"2002","journal-title":"J Biol Chem"},{"key":"2022031223455349000_B9","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/nature03967","article-title":"The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism","volume":"437","author":"Koo","year":"2005","journal-title":"Nature"},{"key":"2022031223455349000_B10","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI200112876","article-title":"The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression","volume":"108","author":"Nakae","year":"2001","journal-title":"J Clin Invest"},{"key":"2022031223455349000_B11","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1128\/MCB.15.3.1747","article-title":"Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes","volume":"15","author":"O\u2019Brien","year":"1995","journal-title":"Mol Cell Biol"},{"key":"2022031223455349000_B12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/35093050","article-title":"Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1","volume":"413","author":"Yoon","year":"2001","journal-title":"Nature"},{"key":"2022031223455349000_B13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cmet.2007.03.004","article-title":"Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver","volume":"5","author":"Burgess","year":"2007","journal-title":"Cell Metab"},{"key":"2022031223455349000_B14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cmet.2009.06.006","article-title":"CRTC2 (TORC2) contributes to the transcriptional response to fasting in the liver but is not required for the maintenance of glucose homeostasis","volume":"10","author":"Le Lay","year":"2009","journal-title":"Cell Metab"},{"key":"2022031223455349000_B15","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2337\/db09-1625","article-title":"Molecular characterization of insulin-mediated suppression of hepatic glucose production in vivo","volume":"59","author":"Ramnanan","year":"2010","journal-title":"Diabetes"},{"key":"2022031223455349000_B16","doi-asserted-by":"crossref","first-page":"19113","DOI":"10.1074\/jbc.M610759200","article-title":"Specific reduction of hepatic glucose 6-phosphate transporter-1 ameliorates diabetes while avoiding complications of glycogen storage disease","volume":"282","author":"Sloop","year":"2007","journal-title":"J Biol Chem"},{"key":"2022031223455349000_B17","doi-asserted-by":"crossref","first-page":"12121","DOI":"10.1073\/pnas.0812547106","article-title":"Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with type 2 diabetes","volume":"106","author":"Samuel","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022031223455349000_B18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1042\/BJ20080709","article-title":"Structure, mechanism and regulation of pyruvate carboxylase","volume":"413","author":"Jitrapakdee","year":"2008","journal-title":"Biochem J"},{"key":"2022031223455349000_B19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1042\/bj1880601","article-title":"Effect of streptozotocin-induced diabetes mellitus on the turnover of rat liver pyruvate carboxylase and pyruvate dehydrogenase","volume":"188","author":"Weinberg","year":"1980","journal-title":"Biochem J"},{"key":"2022031223455349000_B20","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2337\/diabetes.48.6.1251","article-title":"Modifications of citric acid cycle activity and gluconeogenesis in streptozotocin-induced diabetes and effects of metformin","volume":"48","author":"Large","year":"1999","journal-title":"Diabetes"},{"key":"2022031223455349000_B21","doi-asserted-by":"crossref","first-page":"34422","DOI":"10.1074\/jbc.273.51.34422","article-title":"Regulation of rat pyruvate carboxylase gene expression by alternate promoters during development, in genetically obese rats and in insulin-secreting cells. Multiple transcripts with 5\u2032-end heterogeneity modulate translation","volume":"273","author":"Jitrapakdee","year":"1998","journal-title":"J Biol Chem"},{"key":"2022031223455349000_B22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0006-2952(96)00660-0","article-title":"In vitro and in vivo suppression of gluconeogenesis by inhibition of pyruvate carboxylase","volume":"53","author":"Bahl","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"2022031223455349000_B23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.cmet.2009.01.011","article-title":"The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance","volume":"9","author":"Nagai","year":"2009","journal-title":"Cell Metab"},{"key":"2022031223455349000_B24","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/nbt759","article-title":"Systemically delivered antisense oligomers upregulate gene expression in mouse tissues","volume":"20","author":"Sazani","year":"2002","journal-title":"Nat Biotechnol"},{"key":"2022031223455349000_B25","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/archsurg.2007.77","article-title":"Association of morbid obesity with FTO and INSIG2 allelic variants","volume":"143","author":"Chu","year":"2008","journal-title":"Arch Surg"},{"key":"2022031223455349000_B26","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/hep.26170","article-title":"Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats","volume":"57","author":"Kumashiro","year":"2013","journal-title":"Hepatology"},{"key":"2022031223455349000_B27","doi-asserted-by":"crossref","first-page":"16381","DOI":"10.1073\/pnas.1113359108","article-title":"Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease","volume":"108","author":"Kumashiro","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022031223455349000_B28","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0305-0491(91)90378-Q","article-title":"The intracellular distribution and activities of phosphoenolpyruvate carboxykinase isozymes in various tissues of several mammals and birds","volume":"100","author":"Wiese","year":"1991","journal-title":"Comp Biochem Physiol B"},{"key":"2022031223455349000_B29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0003-2697(79)90582-7","article-title":"Determination of phosphoenolpyruvate carboxykinase activity with deoxyguanosine 5\u2032-diphosphate as nucleotide substrate","volume":"96","author":"Petrescu","year":"1979","journal-title":"Anal Biochem"},{"key":"2022031223455349000_B30","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.2337\/db08-0144","article-title":"Impact of oxidative stress and peroxisome proliferator-activated receptor gamma coactivator-1alpha in hepatic insulin resistance","volume":"57","author":"Kumashiro","year":"2008","journal-title":"Diabetes"},{"key":"2022031223455349000_B31","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI30400","article-title":"Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease","volume":"117","author":"Samuel","year":"2007","journal-title":"J Clin Invest"},{"key":"2022031223455349000_B32","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cmet.2011.06.009","article-title":"Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice","volume":"14","author":"Birkenfeld","year":"2011","journal-title":"Cell Metab"},{"key":"2022031223455349000_B33","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1074\/jbc.M808668200","article-title":"Triglyceride synthesis in epididymal adipose tissue: contribution of glucose and non-glucose carbon sources","volume":"284","author":"Bederman","year":"2009","journal-title":"J Biol Chem"},{"key":"2022031223455349000_B34","doi-asserted-by":"crossref","first-page":"E790","DOI":"10.1152\/ajpendo.00402.2002","article-title":"Measurement of TG synthesis and turnover in vivo by 2H2O incorporation into the glycerol moiety and application of MIDA","volume":"285","author":"Turner","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031223455349000_B35","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"2022031223455349000_B36","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00018-005-5410-y","article-title":"Anaplerotic roles of pyruvate carboxylase in mammalian tissues","volume":"63","author":"Jitrapakdee","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"2022031223455349000_B37","doi-asserted-by":"crossref","first-page":"27466","DOI":"10.1074\/jbc.M503836200","article-title":"The peroxisome proliferator-activated receptor-gamma regulates murine pyruvate carboxylase gene expression in vivo and in vitro","volume":"280","author":"Jitrapakdee","year":"2005","journal-title":"J Biol Chem"},{"key":"2022031223455349000_B38","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1210\/en.2003-1580","article-title":"Interaction of tumor necrosis factor-alpha- and thiazolidinedione-regulated pathways in obesity","volume":"145","author":"Wellen","year":"2004","journal-title":"Endocrinology"},{"key":"2022031223455349000_B39","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1172\/JCI21752","article-title":"Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone","volume":"114","author":"Wilson-Fritch","year":"2004","journal-title":"J Clin Invest"},{"key":"2022031223455349000_B40","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/BF00283657","article-title":"On the estimation of absorption of subcutaneous injected insulin from plasma concentrations using mathematical models","volume":"26","author":"Cobelli","year":"1984","journal-title":"Diabetologia"},{"key":"2022031223455349000_B41","doi-asserted-by":"crossref","first-page":"E67","DOI":"10.1152\/ajpendo.00529.2004","article-title":"Mechanisms for abnormal postprandial glucose metabolism in type 2 diabetes","volume":"290","author":"Woerle","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031223455349000_B42","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cmet.2011.11.004","article-title":"Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease","volume":"14","author":"Sunny","year":"2011","journal-title":"Cell Metab"},{"key":"2022031223455349000_B43","doi-asserted-by":"crossref","first-page":"718","DOI":"10.2337\/diabetes.49.5.718","article-title":"Glucose-regulated anaplerosis and cataplerosis in pancreatic beta-cells: possible implication of a pyruvate\/citrate shuttle in insulin secretion","volume":"49","author":"Farfari","year":"2000","journal-title":"Diabetes"},{"key":"2022031223455349000_B44","doi-asserted-by":"crossref","first-page":"20522","DOI":"10.1074\/jbc.272.33.20522","article-title":"The rat pyruvate carboxylase gene structure. Alternate promoters generate multiple transcripts with the 5\u2032-end heterogeneity","volume":"272","author":"Jitrapakdee","year":"1997","journal-title":"J Biol Chem"},{"key":"2022031223455349000_B45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ymgme.2010.05.004","article-title":"Pyruvate carboxylase deficiency: mechanisms, mimics and anaplerosis","volume":"101","author":"Marin-Valencia","year":"2010","journal-title":"Mol Genet Metab"},{"key":"2022031223455349000_B46","doi-asserted-by":"crossref","first-page":"48941","DOI":"10.1074\/jbc.M407120200","article-title":"Impaired tricarboxylic acid cycle activity in mouse livers lacking cytosolic phosphoenolpyruvate carboxykinase","volume":"279","author":"Burgess","year":"2004","journal-title":"J Biol Chem"},{"key":"2022031223455349000_B47","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.2337\/diabetes.50.11.2591","article-title":"Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats","volume":"50","author":"Bandsma","year":"2001","journal-title":"Diabetes"},{"key":"2022031223455349000_B48","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.2337\/db05-1443","article-title":"Inhibition of fructose 1,6-bisphosphatase reduces excessive endogenous glucose production and attenuates hyperglycemia in Zucker diabetic fatty rats","volume":"55","author":"van Poelje","year":"2006","journal-title":"Diabetes"},{"key":"2022031223455349000_B49","doi-asserted-by":"crossref","first-page":"25396","DOI":"10.1074\/jbc.M413948200","article-title":"Physiologic and pharmacologic factors influencing glyceroneogenic contribution to triacylglyceride glycerol measured by mass isotopomer distribution analysis","volume":"280","author":"Chen","year":"2005","journal-title":"J Biol Chem"},{"key":"2022031223455349000_B50","doi-asserted-by":"crossref","first-page":"27565","DOI":"10.1074\/jbc.M804393200","article-title":"Glyceroneogenesis is the dominant pathway for triglyceride glycerol synthesis in vivo in the rat","volume":"283","author":"Nye","year":"2008","journal-title":"J Biol Chem"},{"key":"2022031223455349000_B51","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1194\/jlr.M005363","article-title":"Phosphoenolpyruvate carboxykinase (Pck1) helps regulate the triglyceride\/fatty acid cycle and development of insulin resistance in mice","volume":"51","author":"Millward","year":"2010","journal-title":"J Lipid Res"},{"key":"2022031223455349000_B52","doi-asserted-by":"crossref","first-page":"32345","DOI":"10.1074\/jbc.M313478200","article-title":"Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease","volume":"279","author":"Samuel","year":"2004","journal-title":"J Biol Chem"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/62\/7\/2183\/574689\/2183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/62\/7\/2183\/574689\/2183.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:33:55Z","timestamp":1667406835000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/62\/7\/2183\/33805\/Targeting-Pyruvate-Carboxylase-Reduces"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,14]]},"references-count":52,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,6,14]]},"published-print":{"date-parts":[[2013,7,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db12-1311","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,14]]}}}